Christoph Nienaber | Cardiovascular Medicine | Excellence in Academia Award

Published on by Global Academic Awards

Excellence in Academia Award

Christoph Nienaber
Affiliation Royal Brompton and Harefield Hospitals
Country United Kingdom
Scholar ID pWDqkeQAAAAJ
Documents 1435
Citations 76,690
h-index 121
Subject Area Physical Activity
Event Global Academic Awards

Christoph Nienaber
Royal Brompton and Harefield Hospitals

Christoph Nienaber has established an internationally recognized academic profile through an extensive publication record, substantial citation impact, and continued contributions to cardiovascular medicine and clinical research. His scholarly influence is reflected through widely cited publications, interdisciplinary collaboration, and long-term engagement in evidence-based medical science.[1]

Abstract

Christoph Nienaber has developed an extensive academic career characterized by high-impact research, broad international collaboration, and significant scientific influence. Bibliometric indicators, including more than 1,400 indexed publications, over 76,000 citations, and an h-index exceeding one hundred, demonstrate sustained scholarly productivity and lasting academic impact. These indicators support recognition for long-term excellence in research and higher education.[1]

Keywords

  • Academic Excellence
  • Cardiovascular Medicine
  • Clinical Research
  • Evidence-Based Medicine
  • Scientific Leadership
  • Research Impact

Introduction

Academic excellence encompasses sustained scientific productivity, innovation, mentorship, and contributions that influence research, education, and clinical practice. Recognition through academic awards acknowledges individuals whose scholarly achievements have advanced knowledge within their respective disciplines and contributed to global scientific development.[2]

Research Profile

Christoph Nienaber is affiliated with Royal Brompton and Harefield Hospitals in the United Kingdom. His Google Scholar profile reports approximately 1,435 scholarly publications, over 76,690 citations, and an h-index of 121. These bibliometric measures illustrate exceptional academic productivity and a substantial influence on contemporary cardiovascular research.[1]

Research Contributions

  • Advancement of cardiovascular medicine and clinical cardiology.
  • Leadership in translational and evidence-based clinical research.
  • Extensive peer-reviewed scientific publications.
  • International collaboration and multidisciplinary research initiatives.
  • Contribution to clinical guidelines and medical education.

Publications

The researcher’s publication portfolio spans cardiovascular medicine, vascular diseases, clinical imaging, intervention, and translational healthcare research. Numerous articles have appeared in internationally recognized peer-reviewed journals and continue to receive substantial scholarly citations.[1]

Research Impact

High publication output combined with extensive citation performance demonstrates enduring scientific influence. The researcher’s work has contributed to clinical decision-making, medical education, and continued advancement of cardiovascular science through internationally recognized scholarly communication.[1]

Award Suitability

Based on publicly available bibliometric indicators and documented scholarly achievements, Christoph Nienaber demonstrates the characteristics commonly associated with recipients of academic excellence awards, including sustained publication productivity, exceptional citation impact, international scientific visibility, and long-term contributions to research and higher education. Final award determinations remain subject to independent evaluation by the awarding organization.[3]

Conclusion

Christoph Nienaber’s extensive scholarly record reflects sustained academic excellence, influential research, and meaningful contributions to cardiovascular medicine. His long-standing commitment to scientific inquiry, publication, and international collaboration illustrates the qualities recognized through the Excellence in Academia Award.

References

  1. Google Scholar. (n.d.). Author profile: Christoph Nienaber.
    https://scholar.google.com/citations?user=pWDqkeQAAAAJ&hl=en&oi=sra
  2. Aortic Diameter ≥5.5 cm Is Not a Good Predictor of Type A Aortic Dissection: Observations From the International Registry of Acute Aortic Dissection (IRAD).
    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.107.702720
  3. Randomized Comparison of Strategies for Type B Aortic Dissection: The INvestigation of STEnt Grafts in Aortic Dissection (INSTEAD) Trial.
    https://www.ahajournals.org/doi/full/10.1161/CIRCULATIONAHA.109.886408

 

Ankit Agrawal | Cardiology | Research Excellence Award

Published on by Global Academic Awards

Dr. Ankit Agrawal | Cardiology | Research Excellence Award

Dr. Ankit Agrawal is a cardiology fellow at the University of Arkansas for Medical Sciences with 943 citations, h-index 18, and 33 i10-index. His research spans structural cardiology, transcatheter valve therapies, pericardial diseases, cardiovascular imaging, meta-analyses, and outcomes research, emphasizing evidence-based strategies to improve cardiovascular care and patient safety.

Citation Metrics (Google Scholar)

1000

800

600

400

200

0

Citations 943

Documents 40+

h-index
18


View Google Scholar Profile

Featured Publications

Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

Published on by Global Academic Awards

Prof. Vincenzo Ezio Santobuono | Cardiovascular Disease | Innovative Research Award

University of Bari Aldo Moro | Italy

Prof. Vincenzo Ezio Santobuono is an accomplished cardiologist and academic with a Classical High School Diploma (1999), a Degree in Medicine and Surgery from the University of Bari (2006, summa cum laude), a Specialization in Cardiology (2011, summa cum laude), and a PhD in Experimental and Forensic Medicine and Pathology (2015). He has built a distinguished career combining clinical expertise, academic leadership, and pioneering research in cardiology, particularly in telecardiology, remote monitoring, arrhythmia management, and cardiac resynchronization therapy. Professionally, he has served as Medical Director at the Regional TeleCardiology Center of Bari, specialist consultant for military and governmental institutions, and lecturer at the University of Bari “Aldo Moro” across nursing, medicine, radiology, psychiatric rehabilitation, and cardiovascular disease programs. Currently, he is a fixed-term researcher (RTD-A) leading an innovative project on telecardiology integration within hospital-territory networks. His academic impact is reflected in Scopus metrics with 502 citations, 52 indexed documents, and an h-index of 11, alongside numerous high-impact publications and a patent on supraventricular arrhythmia treatment. Fluent in English and Italian, he actively contributes to cardiovascular innovation, bridging advanced clinical practice with technological solutions to improve patient-centered care and healthcare delivery.

Profile: Scopus | Orcid

Featured Publications

  • Santobuono, V. E., et al. (2025). NPPA-associated atrial dilated cardiomyopathy: Genotypic and phenotypic insights from an ultrarare inherited disorder.

  • Santobuono, V. E., et al. (2025). Differentiating sensor changes in a composite heart failure ICD monitoring index: Clinical correlates and implications.

  • Santobuono, V. E., et al. (2025). Association between device-detected subclinical atrial fibrillation and diabetes in patients with implantable cardioverter-defibrillators: A propensity score-matched analysis. International Journal of Cardiology.

  • Santobuono, V. E., et al. (2025). Kinetics of procalcitonin, CRP, IL-6, and presepsin in heart transplant patients undergoing induction with thymoglobulin (rATG). Journal of Clinical Medicine.

  • Santobuono, V. E., et al. (2025). Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators.

Mehmet Arif İçer | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Assist. Prof. Dr. Mehmet Arif İçer | Cardiology | Best Researcher Award

Assist. Prof. Dr. Mehmet Arif İçer, Amasya University, Turkey

Assist. Prof. Dr. Mehmet Arif İçer is a dedicated academic at the Department of Nutrition and Dietetics, Amasya University, Turkey. With a PhD from Gazi University 🎓, he has authored over 28 impactful research articles in top journals, achieving 980+ citations and an h-index of 11. His work focuses on clinical nutrition, dietary biomarkers, and metabolic health. He was named among Stanford’s Top 2% Scientists in 2024. He also serves as Head of Department and Vice Dean at Amasya University, reflecting his academic leadership. He is passionate about evidence-based nutrition and public health

Publication Profile

Google Scholar

🎓 Educational Background

Assist. Prof. Dr. Mehmet Arif İçer pursued his academic journey in Nutrition and Dietetics with distinction. He earned his PhD (2018–2022) and MSc (2016–2018) from Gazi University in Ankara, Turkey . He completed his BSc at Erciyes University, Kayseri (2009–2014), where he laid the foundation for his expertise in clinical nutrition and dietetics . Enhancing his global perspective, he participated in the Erasmus program at Semmelweis University, Budapest , during 2014. His strong academic background reflects a commitment to excellence and innovation in nutritional science and public health education

Professional Experience

Dr. Mehmet Arif İçer began his academic career as a Research Assistant at Amasya University (2014–2015) 🏫, later continuing at Gazi University from 2015 to 2022 🧪. In 2022, he returned to Amasya University as an Assistant Professor 👨‍🔬. His leadership capabilities led to appointments as the Head of the Department of Nutrition and Dietetics and Vice Dean of the Faculty of Health Sciences in 2023. Dr. İçer’s career reflects a strong dedication to research, academic development, and administrative excellence within the fields of nutrition and public health sciences

🔬 Research Focus

Dr. Mehmet Arif İçer’s research primarily explores the intersection of clinical nutrition, biochemistry, and chronic disease prevention. His studies focus on biomarkers like fetuin-A and osteopontin in metabolic and cardiovascular disorders . He also investigates orthorexia nervosa, kidney stones, and gut-brain axis interactions, particularly through the roles of dietary lipids, microbiota, and lactic acid bacteria 🧬🥦. His multidisciplinary approach bridges nutritional genomics, dietary behavior, and public health 🩺📊. With a strong emphasis on evidence-based dietary strategies, Dr. İçer contributes to advancing preventive health through innovative nutrition science and functional food research

Publication Top Notes

📘 The multiple functions and mechanisms of osteopontin – 653 citations 📈 (2018) 🧬
📘 Effects of fetuin-A with diverse functions and multiple mechanisms on human health – 62 citations 📊 (2021) 🧠
📘 The roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus – 52 citations 🔬 (2023) 🥑🧠
📘 Effects of vitamin E on neurodegenerative diseases: An update – 42 citations 🧠 (2021) 🍊
📘 The impacts of acidophilic lactic acid bacteria on food and human health – 39 citations 🧪 (2023) 🥛
📘 Urine osteopontin levels in nephrolithiasis diagnosis – 28 citations 🧫 (2018) 🧂
📘 Effects of nutritional status on serum fetuin-A level – 25 citations 🧍‍♂️ (2020) 🧪
📘 GABA by lactic acid bacteria & human health – 17 citations 🧠 (2024) 🥬
📘 Pharmacological effects of licorice on human health – 16 citations 🌿 (2017) ⚕️
📘 Healthy food/activity choices & body weight in preschool children – 13 citations 🧒 (2017) 🥗
📘 Effects of red pepper, ginger, turmeric on energy metabolism – 11 citations 🌶️ (2021) 🔥
📘 Dietary intake & kidney stone formation risk – 9 citations 🥤 (2019) 💎
📘 PRAL level in nephrolithiasis patients & nutritional status – 5 citations 🧂 (2018) 🧪
📘 Coffee’s cardiometabolic potential & health relationships – 4 citations ☕ (2024) ❤️

HASAN SARI | Cardiology | Best Researcher Award

Published on by Global Academic Awards

Dr. HASAN SARI | Cardiology | Best Researcher Award

Dr. HASAN SARI, Mut State Hospital, Turkey

Dr. Hasan Sarı (b. 01.12.1991, Manavgat/Antalya) is a specialist in Cardiology. With several published works in leading journals, Dr. Sarı has contributed extensively to the fields of cardiac tumors, syncope, and aortic aneurysms. Notable publications include studies on malignant fibrous histiocytoma, right atrial thrombosis, and coronary ectasia. He has also presented at international conferences, including the ACC Middle East & Eastern Mediterranean 2023 in Athens. Dr. Sarı completed an observership at the University of Minnesota Medical Center in 2023. He is actively engaged in advancing cardiology research. 📚💉❤️📈

 

Publication Profile

Orcid

Research Focus

Dr. Hasan Sarı’s research primarily focuses on cardiology with a special interest in coronary artery diseases, cardiac arrhythmias, vascular pathology, and predictive models for cardiovascular conditions. His work includes evaluating the relationship between coronary ectasia and trimethylamine N-oxide, as well as exploring CHA2DS2-VASc scores and left ventricular apical thrombosis in heart failure patients. His research contributes to advancing cardiac diagnostics, understanding heart failure, and identifying biomarkers for cardiovascular health. Dr. Sarı’s publications are crucial for clinical practice and prevention strategies in cardiology. 🫀🔬💉📊

 

Publication Top Notes 📚

  • “The Evaluation of the Relationship Between Coronary Ectasia and Trimethylamine N‐Oxide” – International Journal of Clinical Practice (2024) 📅📝
  • “Kalp Yetmezlikli Hastalarda CHA2DS2-VASc Skoru ve Sol Ventrikül Apikal Trombozu İlişkisi” – Online Türk Sağlık Bilimleri Dergisi (2022) 📅📝

Guanwei Fan | Cardiovascular research | Best Researcher Award

Published on by Global Academic Awards

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. 📚❤️

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes  

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-κB signaling pathway. Journal of Ethnopharmacology, 2024. 📖
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. 📖
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. 📖
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice. Phytomedicine, 2024. 📖
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. 📖
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. 📖
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. 📖
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. 📖